AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease.
@AASLDFoundation @AASLDPresident
🎉 Join us in celebrating the #AASLD 2026 Distinguished Award recipients!
Learn more about their remarkable contributions and accomplishments in #hepatology: https://t.co/j7q5zaBL4v
Spontaneous HDV suppression is rare, but it is predictable, and that changes how treatment timing gets approached.
New data from 1,610 patients identifies the key markers: lower baseline HBsAg, HDV RNA, and ALT, plus male sex and diabetes.
Research like this is driving hepatology forward. Join the global community advancing it at #TLM26 this November in Denver.
Full study in Hepatology: https://t.co/HPHsfeNEda
#HepatitisD #HDV #Hepatology #AASLD
Stay ahead during Men’s Health Month by exploring best practices in #MASH and #MASLD for the male patients in your care! Access AASLD’s free course today and support their metabolic health through early detection of steatotic liver disease (SLD). Start now: https://t.co/oT497vbNEB
🎉 AASLD is excited to announce the 2026 Editorial Fellows for @HEP_Journal and @LTxJournal!
The 2026 Editorial Fellows will gain unique, hands-on experience in scholarly publishing and journal editorial leadership while working alongside experienced editors at two of the field’s leading hepatology journals.
Learn more: https://t.co/NuQeD4gzUP.
🏆 Four days left to make an impact!
The new #AASLD Impact Award honors members making meaningful contributions across research, clinical care, education, mentorship, and innovation, with a clear trajectory toward future leadership in the field.
Submit a nomination in less than 10 minutes! Self-nominate or nominate a peer before June 7.
👉 Be part of recognizing excellence across the AASLD community, nominate today: https://t.co/pkjTsl0E1V.
The countdown is on for #SLAM2026!
Have you registered yet? AASLD members receive an exclusive discount on registration, making now the perfect time to secure your spot.
Register today and join us June 14–18 in Cape Coral, Florida. https://t.co/xJGpJxz8wo
Hear from an Infectious Disease doctor on what it means to be part of nearly 9,000 attendees from 80+ countries, all brought together at The Liver Meeting. With over 2,400 poster presentations and hundreds of hours of educational content, it's one of the most comprehensive and inclusive gatherings in hepatology.
#TLM26 #Hepatology #InfectiousDisease #MedEd
🌈Happy #PrideMonth from AASLD!
This month and every month, AASLD is proud to support and uplift the LGBTQ+ community through education, advocacy, inclusion, and connection.
From our #LGBTQ+ webinars and the annual #PRIDE reception at #TLM, to the ongoing efforts of the Inclusion and Diversity Committee and Public Policy Committee, AASLD remains committed to creating a more inclusive and welcoming #hepatology community for all.
Looking to strengthen your approach to #viralhepatitis care? AASLD endorses Medscape® Education’s newest activities, where you will learn practical strategies to improve workflows, engage patients, and help close care gaps.
Assess Your Workflows Today: https://t.co/eVRdKKixwb
📣Calling all early-career women in #hepatology!
The deadline to apply for the #AASLD Women’s Leadership Development Program has been extended to June 26.
Empower your future with this unique opportunity to build leadership skills, connect with senior mentors, and grow your impact in the field.
➡️Take the next step and apply today: https://t.co/nt7wprJzTB
Hear directly from AASLD Senior Councilor and program chair Rotonya Carr, MD, FACP, FAASLD to see why you should apply for the 2026 AASLD-EASL Masterclass. Applications close on June 15, get started now: https://t.co/d9QC7adUQr
BREAKING NEWS: A major milestone for people living with #HepatitisD.
The FDA has approved #bulevirtide (#Hepcludex), the first approved treatment for chronic #HDV infection.
In this news article, #AASLD member Ira M. Jacobson, MD, FAASLD, highlights the potential of this long-awaited therapy to help address a significant unmet need for people living with HDV.
Read more: https://t.co/b8vcGCgR48.
Join AASLD and @INASL_Liver on June 11 at 11 a.m. EDT for an annual joint webinar on #MASH diagnosis and treatment. Explore non-invasive testing strategies, innovative therapies like resmetirom and semaglutide, and integrated management approaches for MASH patients. Learn More and Register: https://t.co/j1izMTkVhZ
This #HepatitisAwarenessMonth, Chair of the #AASLD Public Policy Committee, Julius M. Wilder, MD, PhD, FAASLD, highlights a critical message: We have made tremendous progress in #hepatitis screening and treatment, but too many people still remain unscreened.
Continued advocacy, innovation, research funding, and action will be essential to advancing equitable access to care and moving closer to hepatitis elimination.
Learn more about AASLD advocacy and policy efforts: https://t.co/rNqfDwWr9a.
Now online in @HEP_Journal!
Developed through broad international collaboration, these two new global consensus statements provide critical guidance and help advance global alignment in #hepatology research, diagnosis, and clinical care. #PSVD#NCPF#PrimaryBiliaryCholangitis #PBC
Learn more here: https://t.co/tpRoaz83hZ
Ready to become a trusted source of care for those in the LGBTQ+ community? Register for our June 9 webinar and learn to provide stigma-free, affirming sexual healthcare while addressing topics such as viral hepatitis prevention in MSM and transgender populations. Register now: https://t.co/zNJhEuzG1b
⏳You have TWO DAYS left to help shape the future of liver health! With 24 available abstract categories, including #HCC, #ALD, #MASLD, and #MASH, there is an opportunity waiting for you.
📝Submit your groundbreaking abstract today: https://t.co/dsoMD9mf8Y
🏆 Did you know?
You can nominate or self-nominate for the new AASLD Impact Award in less than 10 minutes!
Be part of recognizing excellence across the AASLD community.
👉 Self-nominate or nominate a peer before June 7 online here: https://t.co/HHbJaJ7Xru